Back to top
more

Select Medical (SEM)

(Real Time Quote from BATS)

$33.23 USD

33.23
16,338

-0.51 (-1.51%)

Updated Sep 9, 2024 10:00 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (212 out of 249)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Is Molina Healthcare (MOH) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Kinjel Shah headshot

5 Low Price-to-Book Stocks to Add Value to Your Portfolio

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Vishay Intertechnology (VSH), Group 1 Automotive (GPI), Celestica (CLS), Select Medical Holdings Corporation (SEM) and Signet Jewelers Limited (SIG) are some such stocks.

Select Medical (SEM), Inova Health Form JV in Northern Virginia

by Zacks Equity Research

The JV between Select Medical (SEM) and Inova Health System is expected to own and operate a new 32-bed critical illness recovery facility.

Why You Should Retain Humana (HUM) in Your Portfolio Now

by Zacks Equity Research

Humana's (HUM) strategic acquisitions help it boost its footprint and expand the product portfolio.

Will Mednax's (MD) New Name Pediatrix Medical be Beneficial?

by Zacks Equity Research

Mednax's (MD) name change is expected to take effect following the closing bell on Jul 1, 2022.

    UnitedHealth (UNH) Unit Eyes $1.5B EMIS Acquisition in UK

    by Zacks Equity Research

    UnitedHealth's (UNH) Optum business operates in the United Kingdom for two decades and the acquisition is expected to boost its footprint in the country.

    Centene (CNC) Raises 2022 Guidance, Ups Share Buyback Fund

    by Zacks Equity Research

    Currently, Centene (CNC) has $3.6 billion remaining under its share buyback program.

    Is Select Medical (SEM) a Great Value Stock Right Now?

    by Zacks Equity Research

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    Cigna (CI) Signs $3.5B Accelerated Share Buyback Agreements

    by Zacks Equity Research

    Cigna (CI) intends to buy back at least $7 billion worth of its stocks this year alone.

    Sanghamitra Saha headshot

    5 Stocks Likely to Give Sweet Surprises on Earnings

    by Sanghamitra Saha

    These top-ranked stocks are likely to beat on the bottom line in their next releases.

      Encompass Health (EHC) Forms JV With NCH Healthcare in Naples

      by Zacks Equity Research

      The NCH Healthcare System's board grants approval to invest in the joint venture with Encompass Health (EHC).

      Encompass Health (EHC) Plans to Distribute Enhabit Shares

      by Zacks Equity Research

      Every Encompass Health (EHC) shareholder will receive one Enhabit common share for every two EHC common shares held.

      Should You Hold On to Teladoc Health (TDOC) Stock for Now?

      by Zacks Equity Research

      Teladoc Health's (TDOC) cash flows will likely gain from the growing number of visits and memberships.

      Humana (HUM) Unveils Transition of Units to CenterWell Brand

      by Zacks Equity Research

      Humana (HUM) announces the rebranding of its pharmacy divisions to the CenterWell brand, reflecting the rapid expansion initiatives to grow the brand and better serve members.

      Select Medical (SEM) Inks JV to Serve Venice and Nearby Areas

      by Zacks Equity Research

      Select Medical (SEM) teams up with Community Health's arm, ShorePoint Health Venice, for jointly operating a hospital dedicated to serve post-acute care needs of patients.

      HCA Healthcare's (HCA) Galen College Adds 8th New Facility

      by Zacks Equity Research

      HCA Healthcare's (HCA) Galen College nursing campus addition comes when the country is suffering from a nursing shortage.

      Humana (HUM) to Offer Home Care Model to Virginia's MA Members

      by Zacks Equity Research

      Humana (HUM) expands the customer reach of its unit's value-based home care model to Virginia, with an aim to offer better in-home care services to the state's Medicare Advantage members.

      Here's Why Investors Should Bet on Cigna (CI) Stock Now

      by Zacks Equity Research

      Cigna (CI) expects 2022 medical customers to grow by a minimum of 725,000, suggesting an upside from the prior projection.

      UnitedHealth (UNH) Rewards Shareholders With 13.8% Dividend Hike

      by Zacks Equity Research

      UnitedHealth's (UNH) strong balance sheet supports its endeavors to return shareholders' funds.

      Encompass Health (EHC) Updates 2022 Guidance: Dips 5.4%

      by Zacks Equity Research

      Encompass Health (EHC) expects to retain its cash dividend routine. However, the amount might decline to reflect the spin-off of the home health and hospice business.

      Ensign Group (ENSG) Up 3.7% in 30 Days: More Room to Rally?

      by Zacks Equity Research

      Ensign Group's (ENSG) rising profits from Skilled Services business are a major positive.

      HCA Healthcare's (HCA) Utah Acquisition Faces Fed Roadblocks

      by Zacks Equity Research

      The trade watchdog expects HCA Healthcare's (HCA) Utah acquisition to induce market concentration and eliminate Steward Health Care as a low-cost competitor.

      Zacks Industry Outlook Highlights UnitedHealth Group Anthem, Humana, Centene, and Select Medical

      by Zacks Equity Research

      UnitedHealth Group, Anthem, Humana, Centene, and Select Medical are part of Zacks Industry Outlook article.

      Debasmita Chatterjee headshot

      5 HMO Stocks Set to Gain From Membership Growth, M&A Strategy

      by Debasmita Chatterjee

      Rising membership and a rapidly growing aging U.S. population are likely to drive the performances of the Zacks Medical-HMO industry players. UNH, ANTM, HUM, CNC and SEM are poised to benefit from improved operational efficiencies.

      Wall Street Analysts Believe Select Medical (SEM) Could Rally 75%: Here's is How to Trade

      by Zacks Equity Research

      The consensus price target hints at a 74.5% upside potential for Select Medical (SEM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.